Singapore charts ambitious research commercialisation roadmap with S$37bn investment

Singapore is intensifying efforts to bridge the gap between laboratory discoveries and market applications through a sweeping new research initiative. The National Research Foundation has released full details of its S$37 billion Research, Innovation and Enterprise 2030 (RIE2030) plan, which prioritises converting academic breakthroughs into tangible economic benefits.

The multi-billion dollar programme represents a significant commitment to ensuring Singapore's research ecosystem delivers measurable real-world impact. By focusing on translational research and commercialisation pathways, the initiative seeks to strengthen the island nation's competitive advantage in high-value industries and emerging technologies.

RIE2030 builds upon previous research funding cycles and incorporates lessons learned from earlier programmes. The expanded investment underscores Singapore's determination to cultivate a thriving innovation economy and attract top scientific talent to its institutions and research facilities.

The framework is expected to address critical gaps in the research-to-market pipeline, providing enhanced support for startups, spin-offs and collaborations between academic institutions and industry partners. The initiative aligns with Singapore's broader economic strategies to diversify revenue streams and position itself as a knowledge-driven economy in an increasingly competitive Asian landscape.